SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-206427
Filing Date
2021-07-01
Accepted
2021-07-01 16:44:35
Documents
4
Period of Report
2021-06-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d12343d8ka.htm 8-K/A 27707
2 EX-16.1 d12343dex161.htm EX-16.1 2669
3 EX-99.1 d12343dex991.htm EX-99.1 303817
4 EX-99.2 d12343dex992.htm EX-99.2 182802
  Complete submission text file 0001193125-21-206427.txt   518205
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35890 | Film No.: 211066530
SIC: 2834 Pharmaceutical Preparations